Dan Corneliu Blendea

Prof. Dr. Dan Corneliu Blendea


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
Constantin MunteanuConstantin Munteanu
Constantin Munteanu
AGAnca Irina Galaction
Anca Irina Galaction
MTMarius Alexandru Turnea
Marius Alexandru Turnea
DBDan Corneliu Blendea
Dan Corneliu Blendea
MRMariana Rotariu
Mariana Rotariu
Mădălina ParaschivMădălina Paraschiv
Mădălina Paraschiv
Neurodegenerative diseases encompass a spectrum of disorders marked by the progressive degeneration of the structure and function of the nervous system. These conditions, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), Amyotrophic lateral sclerosis (ALS), and Multiple sclerosis (MS), often lead to severe cognitive and motor deficits. A critical component of neurodegenerative disease pathologies is the imbalance between pro-oxidant and antioxidant mechanisms, culminating in oxidative stress. The brain’s high oxygen consumption and lipid-rich environment make it particularly vulnerable to oxidative damage. Pro-oxidants such as reactive nitrogen species (RNS) and reactive oxygen species (ROS) are continuously generated during normal metabolism, counteracted by enzymatic and non-enzymatic antioxidant defenses. In neurodegenerative diseases, this balance is disrupted, leading to neuronal damage. This systematic review explores the roles of oxidative stress, gut microbiota, and epigenetic modifications in neurodegenerative diseases, aiming to elucidate the interplay between these factors and identify potential therapeutic strategies. We conducted a comprehensive search of articles published in 2024 across major databases, focusing on studies examining the relationships between redox homeostasis, gut microbiota, and epigenetic changes in neurodegeneration. A total of 161 studies were included, comprising clinical trials, observational studies, and experimental research. Our findings reveal that oxidative stress plays a central role in the pathogenesis of neurodegenerative diseases, with gut microbiota composition and epigenetic modifications significantly influencing redox balance. Specific bacterial taxa and epigenetic markers were identified as potential modulators of oxidative stress, suggesting novel avenues for therapeutic intervention. Moreover, recent evidence from human and animal studies supports the emerging concept of targeting redox homeostasis through microbiota and epigenetic therapies. Future research should focus on validating these targets in clinical settings and exploring the potential for personalized medicine strategies based on individual microbiota and epigenetic profiles.

26 August 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Constantin MunteanuConstantin Munteanu
Constantin Munteanu
AGAnca Irina Galaction
Anca Irina Galaction
Mădălina ParaschivMădălina Paraschiv
Mădălina Paraschiv
MRMariana Rotariu
Mariana Rotariu
MTMarius Alexandru Turnea
Marius Alexandru Turnea
DBDan Corneliu Blendea
Dan Corneliu Blendea
Atherosclerosis is a chronic inflammatory condition marked by endothelial dysfunction, lipid accumulation, inflammatory cell infiltration, and extracellular matrix (ECM) remodeling within arterial walls, leading to plaque formation and potential cardiovascular events. Key players in ECM remodeling and inflammation are matrix metalloproteinases (MMPs) and CD147/EMMPRIN, a cell surface glycoprotein expressed on endothelial cells, vascular smooth muscle cells (VSMCs), and immune cells, that regulates MMP activity. Hydrogen sulfide (H₂S), a gaseous signaling molecule, has emerged as a significant modulator of these processes including oxidative stress mitigation, inflammation reduction, and vascular remodeling. This systematic review investigates the mechanistic pathways through which H₂S influences MMPs and CD147/EMMPRIN and assesses its impact on atherosclerosis progression. A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science databases, focusing on studies examining H₂S modulation of MMPs and CD147/EMMPRIN in atherosclerosis contexts. Findings indicate that H₂S modulates MMP expression and activity through transcriptional regulation and post-translational modifications, including S-sulfhydration. By mitigating oxidative stress, H₂S reduces MMP activation, contributing to plaque stability and vascular remodeling. H₂S also downregulates CD147/EMMPRIN expression via transcriptional pathways, diminishing inflammatory responses and vascular cellular proliferation within plaques. The dual regulatory role of H₂S in inhibiting MMP activity and downregulating CD147 suggests its potential as a therapeutic agent in stabilizing atherosclerotic plaques and mitigating inflammation. Further research is warranted to elucidate the precise molecular mechanisms and to explore H₂S-based therapies for clinical application in atherosclerosis.

15 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AMAlexandra Ana Mihăilescu
Alexandra Ana Mihăilescu
MOMinodora Onisai
Minodora Onisai
AAAdrian Nicolae Alexandru
Adrian Nicolae Alexandru
MTMatei Teodorescu
Matei Teodorescu
CACatalin Alius
Catalin Alius
SGSebastian Eugen Grdinaru
Sebastian Eugen Grdinaru
Enhanced Recovery After Surgery (ERAS) represents evidence-based transformation in perioperative care, which has been demonstrated to reduce both recovery times and postoperative complication rates. The aim of the present study was to evaluate the clinical significance of the ERAS program in comparison with conventional postoperative care. This longitudinal cohort observational study enrolled 120 consecutive patients diagnosed with intestinal obstruction caused by colorectal cancers, with 40 patients in the ERAS group and 80 patients receiving conventional postoperative care forming the non-ERAS group. Our study compares the effectiveness of ERAS protocols to non-ERAS methods, focusing on the time to first flatus, defecation, the resumption of normal diet, and early mobilization. The main endpoints are morbidity and hospitalization length. The results showed that despite a longer admission-to-surgery interval in the ERAS group, median hospitalization was significantly shorter compared to the non-ERAS group (p = 0.0002). The ERAS group showed a tendency towards a lower incidence of overall postoperative complications, indicating that implementing the ERAS protocol does not increase the risk of postoperative complications, ensuring the safety of enhanced recovery strategies for patients. Also, ERAS patients had notably fewer stomas than those in the non-ERAS group, indicating the potential effectiveness of reducing stoma necessity. This study shows that ERAS surpasses conventional care for colonic or rectal surgery patients, reducing hospital stays and costs while enhancing recovery. This highlights the comprehensive advantages of adopting ERAS in surgical settings.

Verified
Journal Article
Open access
PDF file
Constantin MunteanuConstantin Munteanu
Constantin Munteanu
VBViorela Elena Bembea
Viorela Elena Bembea
YMYuliya Manolaki
Yuliya Manolaki
GOGelu Onose
Gelu Onose
MTMarius Alexandru Turnea
Marius Alexandru Turnea
DBDan Corneliu Blendea
Dan Corneliu Blendea
Type 2 diabetes and obesity are associated with metabolic stress and heterogeneous endothelial and tissue dysfunction. Baseline measurements of analytically specified sulfur species, thiol–disulfide couples, and operational sulfide pools provide limited information about dynamic pathway turnover or the capacity to respond to metabolic demand. This critical narrative review evaluated human and experimental evidence, published in the last twenty years, linking sulfur metabolism, redox regulation and functional responses, and developed a conceptual framework for sulfur-redox adaptive reserve. Human studies report divergent assay-defined circulating sulfide signals, impaired erythrocyte glutathione synthesis, and weight loss accompanied by lower measured sulfide fractions and sulfur metabolites. Experimental findings support sulfur-sensitive regulation of mitochondrial, endothelial, and tissue function, but do not establish a uniform direction of benefit or clinical mediation. We therefore propose sulfur-redox adaptive reserve as the context-dependent, challenge-evoked capacity of endogenous sulfide generation, mitochondrial sulfide oxidation, persulfide turnover, thiol replenishment, and linked redox systems to support preservation or recovery of independently measured endothelial and tissue function during and after a defined metabolic perturbation. Unlike metabolic flexibility, redox homeostasis, or mitochondrial reserve capacity considered separately, the construct requires coordinated sulfur-network responses to a specified perturbation and linkage to independently measured functional outcomes. Its evaluation requires serial analyte-specific measurements, characterization of the achieved internal metabolic response—such as post-challenge glucose, insulin, and triglyceride trajectories or relative exercise intensity—and an independent functional endpoint. Repeated challenge studies must establish reproducibility, incremental information beyond baseline measures, and mechanistic specificity. The framework generates testable hypotheses, but its prognostic value, mechanistic specificity and clinical utility remain to be established.